SME Times is powered by   
Search News
Just in:   • New FTAs fresh boost to manufacturing and innovation, open global opportunities for youth: Piyush Goyal  • India, Japan sign first defence co-development pact to build UNICORN naval masts  • China to face huge economic costs if Taiwan Strait is blocked  • Gold steady, silver slips as Fed rate hike expectations ease  • Defence PSU stocks rally up to 3 pc after Rs 52,000 crore procurement nod 
Last updated: 27 Sep, 2014  

iphex-2013-THMB.jpg SMEs are quite active in "iPHEX"

iphex.jpg
   Top Stories
» Defence PSU stocks rally up to 3 pc after Rs 52,000 crore procurement nod
» Govt holds third preparatory meeting for BRICS Women Track
» Govt introduces 'Improvement Notice' mechanism to boost ease of doing business
» India-US relationship stronger than ever: Trump team charts ambitious agenda
» Piyush Goyal, global CEOs discuss investment opportunities under India-UK CETA
Vaneeta Punchvedi | 07 May, 2014
The Pharmaceuticals Export Promotion Council (Pharmexcil) has invited small and medium enterprises to participate in the three-day pharma exhibition 'iPHEXIS 2014', which will begin on May 21, in Mumbai.

"Govt. is taking care of the pharma industry. "iPHEXIS 2014" is inviting more and more SMEs in this exhibition. More than 400 SMEs have already showed their interest in it. We want new faces, new companies in this industry," Director Genral of the Pharmaexcil PV Appaji said in a press conference of in New Delhi on Tuesday.

Last year a significant no. of SMEs had participated in the exhibition. About 70 percent of stalls were to SMEs.

"The buyers were excited to find new suppliers since this will reduce the cost of procurement and will also reduce health care cost," Bhavin Mehta Committee Chief of iPHEX and CoA member, Pharmexcil further added.

SMEs are playing very pivotal role in Indian pharma industry and its growth as they contribute about 35-40 percent to the industry in terms of production with a turnover of about Rs 35,000 crore.

A report of Indian MSMEs of 2013 also strengthened the fact that how importantly SMEs are supporting the entire pharmaceutical industry in India and its export in other countries.

"The Indian pharmaceutical industry is highly fragmented and estimated to have 9,456 units in the SME segment, which account for around 87 percent in production by volume and 40 percent by value." report said.

In terms of number of units and employment generation, the SME sector is at the forefront. They also support 48 percent of the country's pharma exports, the MSME report added.

There are more than 24,000 registered units, which meet 70 percent of the country's needs. Clearly, MSMEs operating in the domestic pharma sector are recognised as the backbone of the industry.

iPHEX2014" is expected to attract and make SMEs ready to get participate in in this three days. Last time exhibitors almost had done the 1000cr business in in given days.

"iPHEX" is not only a event, it is a place where buyers and sellers meet, make them confident and give them more than 100 choices. "iPHEX" 2013 had witnessed more than 7500 meetings in three days exhibition.

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹95.3
₹93.6
UK Pound
₹127.7
₹123.7
Euro
₹110.65
₹106.9
Japanese Yen ₹59.75 ₹57.9
As on 24 Jun, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter